巴郡副主席看好Zoom 料商務公幹將不復疫前
巴郡(Berkshire Hathaway)(BRK.A.US)(BRK.B.US)副主席芒格接受《CNBC》訪問時表示,相信視像通話應用Zoom(ZM.US)將在新冠疫後繼續蓬勃發展,又稱他每天最少三次使用該應用程式,並透過視像會議達成一項有關澳洲的交易。
芒格認爲,大量商務公幹在疫後將不會回覆,愈來愈多企業選擇每年一至兩次面對面會議,其餘則透過Zoom進行,有關模式將會繼續。他又指辦公室需求面臨困難,大量民衆發現他們不必留在辦公室工作,並決定每週工作三天,其餘時間留家,相信民衆的工作生活將不會回覆至疫前。
但其夥伴,即「股神」巴菲特則表示,仍選擇使用電話進行溝通,並不習慣使用Zoom。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.